About TrueBinding

About company

TrueBinding is an early-stage biotherapeutics development company focused on creating new and exciting molecules for applications in Immuno oncology and other disease areas with a great unmet medical needs. Based on the application of the TruebindingTM platform, TrueBinding has to date discovered 6 novel ligands, previously uncharacterized, to receptors of known checkpoint inhibitor pathways.